At present, there is an intense need demand for effective oral
medication which can facilitate cure of Thrombocytopenia (Low Platelets
count).
Thrombocytopenia affects 44% to 96% of patients
with co-morbid conditions. It leads to an increased risk of life
threaten bleeding which needs emergency hospitalization. This usually
leads to the demise in most cases. At present the most common treatment
of Thrombocytopenia is Platelet Transfusion, Immunoglobulins,
immunosuppressive agents surgical removal of spleen.